Table 4

 Sensitivity (%) of PhiCal and FlexSure OBT for asymptomatic neoplasia in 666 screenees delivering a valid FlexSure OBT test card, having a faecal calprotectin analysis, and being examined to the caecum at colonoscopy

Low risk adenoma (n = 480)High risk adenoma (n = 174)CRC (n = 12)
Positive PhiCal125 (26)43 (25)8 (67)
Positive FlexSure OBT48 (10)56 (32)9 (75)
Any one test positive131 (27)73 (42)5
Both tests positive21 (4.4)13 (7.5)6